“Whiz” Buckley Explains Why FDA Rejected MDMA For PTSD

Sep 4, 2024

Numinus Wellness’ Response to FDA’s MDMA Decision

Aug 12, 2024

Bipartisan Momentum: FDA’s Decision on MDMA Expected by August 11th

Aug 6, 2024

ICER Draft Report Critiques Lykos’ MDMA Therapy for Insufficient Evidence

Apr 1, 2024

Numinus Submits MDMA Group Therapy Clinical Trial Application

Mar 22, 2024

FDA Accepts MDMA PTSD Therapy New Drug Application

Feb 12, 2024

atai Life Sciences Announces Positive Data For Orally Administered MDMA Derivative EMP-01

Jan 2, 2024

FDA Receives NDA From MAPS PBC Regarding MDMA-Assisted Therapy For PTSD

Dec 12, 2023

California Passes Law Enabling MDMA And Psilocybin Prescriptions When Federally Legal

Oct 5, 2023

Tier-1 Medical Journal Publishes Final Results Of Phase 3 MDMA-Assisted Therapy Study

Sep 14, 2023